Supply of Aseptically Prepared Dose Banded Medicines
Estimated value
—
Awarded value
—
Suppliers
8
Lots
28
Published
13 Jul 2022
Total lots
28
Awarded
2
Estimated total
£3.5bn
Awarded total
—
BORTEZOMIB
Start
—
End
—
Estimated
£100.0m
CPV
CARBOPLATIN
Start
—
End
—
Estimated
£100.0m
CPV
CETUXIMAB
Start
—
End
—
Estimated
£100.0m
CPV
CISPLATIN
Start
—
End
—
Estimated
£100.0m
CPV
CYCLOPHOSPHAMIDE
Start
—
End
—
Estimated
£100.0m
CPV
CYTARABINE
Start
—
End
—
Estimated
£100.0m
CPV
DESFERRIOXAMINE
Start
—
End
—
Estimated
£100.0m
CPV
DOCETAXEL
Start
—
End
—
Estimated
£100.0m
CPV
DOXORUBICIN
Start
—
End
—
Estimated
£100.0m
CPV
EPIRUBICIN
Start
—
End
—
Estimated
£100.0m
CPV
FLUOROURACIL
Start
—
End
—
Estimated
£100.0m
CPV
GANCICLOVIR
Start
—
End
—
Estimated
£100.0m
CPV
GEMCITABINE
Start
—
End
—
Estimated
£100.0m
CPV
INFLIXIMAB
Start
—
End
—
Estimated
£100.0m
CPV
IRINOTECAN
Start
—
End
—
Estimated
£100.0m
CPV
METHOTREXATE
Start
—
End
—
Estimated
£100.0m
CPV
NIVOLUMAB
Start
—
End
—
Estimated
£100.0m
CPV
OXALIPLATIN
Start
—
End
—
Estimated
£100.0m
CPV
PACLITAXEL
Start
—
End
—
Estimated
£100.0m
CPV
PEMBROLIZUMAB
Start
—
End
—
Estimated
£100.0m
CPV
PERTUZUMAB
Start
—
End
—
Estimated
£100.0m
CPV
RITUXIMAB
Start
—
End
—
Estimated
£100.0m
CPV
TRASTUZUMAB SC
Start
—
End
—
Estimated
£100.0m
CPV
TRASTUZUMAB IV
Start
—
End
—
Estimated
£100.0m
CPV
VINCRISTINE
Start
—
End
—
Estimated
£100.0m
CPV
Aseptically Prepared Dose Banded Medicines
Start
—
End
—
Estimated
£500.0m
CPV
CIVAS (Centralised Intravenous Additive Service)
Start
—
End
—
Estimated
£200.0m
CPV
Patient Specific Chemotherapy
Start
—
End
—
Estimated
£300.0m
CPV